Jazz Pharmaceuticals (JAZZ) Other financing activities (2016)
Jazz Pharmaceuticals has reported Other financing activities over the past 5 years, most recently at -$3.5 million for Q3 2016.
- Quarterly Other financing activities fell 994.69% to -$3.5 million in Q3 2016 from the year-ago period, while the trailing twelve-month figure was $320000.0 through Sep 2016, up 112.53% year-over-year, with the annual reading at $1.8 million for FY2014, N/A changed from the prior year.
- Other financing activities was -$3.5 million for Q3 2016 at Jazz Pharmaceuticals, up from -$4.4 million in the prior quarter.
- Over five years, Other financing activities peaked at $10.6 million in Q1 2015 and troughed at -$10.6 million in Q2 2015.
- The 5-year median for Other financing activities is $320000.0 (2015), against an average of $741000.0.
- Biggest five-year swings in Other financing activities: soared 3903.66% in 2014 and later crashed 994.69% in 2016.
- Tracing JAZZ's Other financing activities over 5 years: stood at $5.5 million in 2012, then plummeted by 98.51% to $82000.0 in 2013, then plummeted by 2824.39% to -$2.2 million in 2014, then soared by 114.32% to $320000.0 in 2015, then tumbled by 1194.69% to -$3.5 million in 2016.
- According to Business Quant data, Other financing activities over the past three periods came in at -$3.5 million, -$4.4 million, and $7.9 million for Q3 2016, Q2 2016, and Q1 2016 respectively.